Issue Archive
March 2010 | Volume 9 | Issue 3
Editorials
Practical Applications of a New Botulinum Toxin
This supplement to the Journal of Drugs in Dermatology is supported by an educational grant from Medicis Pharmaceutical Corporation....
Read More
Original Articles
Clinical Trial Review
Combat Dermatology: The Prevalence of Skin Disease in a Deployed DermatologyClinic in Iraq
Background: Since July 2004, the United States (U.S.) Army has operated a forward-deployed dermatology clinic in Baghdad, Iraq. This paper outlines the prevalence of skin disease among deployed servi...
Read MoreTolerability and Efficacy of a Novel Formulation in the Treatment of Melasma
Background: Topical agents containing mixtures of hydroquinone and glycolic acid often cause irritation in patients with melasma.
Objective: The authors assessed the safety and efficacy o...
Read MoreTreating Photodamage of the Décolletage Area With a Novel Copper Zinc MalonateComplex Plus Hydroquinone and Tretinoin
There has been a proliferation of treatments for facial rejuvenation but, curiously, the use of such treatments on other areas of the body has not been widely investigated. The clinical effects of tre...
Read MoreAn Open-label, Split-face Study Comparing the Safety and Efficacy of LevulanKerastick (Aminolevulonic Acid) Plus a 532 nm KTP Laser to a 532 nm KTP LaserAlone for the Treatment of Moderate Facial Acne
Recent advances in light therapy coupled with photosensitizers offer alternatives to topical creams and gels and systemic oral agents for acne treatment. To examine the safety and efficacy of the pho...
Read MoreNews, Views and Reviews
Pipeline Previews
Case Reports
The Multifunctionality of 10% Sodium Sulfacetamide, 5% Sulfur Emollient Foamin the Treatment of Inflammatory Facial Dermatoses
Prior to 1962, some of the most versatile drugs in dermatology were approved by the U.S. Food and Drug Administration (FDA) solely on the basis of safety. One of these is the combination 10% sodium s...
Read MorePimecrolimus for Idiopathic Guttate Hypomelanosis
Idiopathic guttate hypomelanosis (IGH) is a very common skin disorder, although the precise prevalence of which is unknown. There are no universally safe and efficacious treatments for this condition...
Read MoreTo Treat or Not to Treat? Management of Guttate Psoriasis and Pityriasis Rosea inPatients With Evidence of Group A Streptococcal Infection
The association between guttate psoriasis and pityriasis rosea with Streptococcus pyogenes (S. pyogenes) is well established in the literature; however treatment guidelines and necessity have not bee...
Read MoreLeech Therapy in Cutaneous Surgery and Disease
Background: Over the ages, the use of leeches in medicine has evolved from haphazard bloodletting to a well-understood physiologic process with defined, rational applications.
Objective:...
Read MorePorokeratosis in a Patient With Hepatitis of Unclear Etiology
Porokeratosis is hypothesized to be an inherited autosomal dominant disorder with variable penetrance. It has been linked to ultraviolet (UV) radiation in genetically predisposed individuals, to anti...
Read MoreIntravenous Immunoglobulin Therapy for Scleromyxedema: A Case Report andReview of Literature
Scleromyxedema is a chronic, idiopathic disorder characterized by cutaneous dermal mucin deposition in association with increased dermal collagen and absence of thyroid disease. The clinical features...
Read MoreIncreased Mast Cell Density in Capecitabine-Induced Hand-Foot Syndrome: A NewPathologic Finding
Hand-foot syndrome is a common adverse effect of therapy with capecitabine (Xeloda®) for the treatment of various carcinomas. Symptoms suggesting hand-foot syndrome include pain, pruritus, erythem...
Read MoreGeneralized Necrobiotic Xanthogranuloma Successfully Treated With Lenalidomide
Necrobiotic xanthogranuloma (NXG) presents a therapeutic challenge to clinicians. Generalized NXG has limited treatment options. A patient presented to the authors with generalized NXG associated wit...
Read More
